KURA ONCOLOGY INC (KURA:NASDAQ)
$9.82 0.2 (2.079%)
Analysed KURA ONCOLOGY INC (KURA:NASDAQ) News Sources
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
08-09-2026
yahoo.com
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
09-09-2026
yahoo.com
Kura spins diabetes work into a Lilly-backed biotech startup
09-09-2026
biopharmadive.com
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
29-09-2026
yahoo.com
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
01-10-2026
yahoo.com
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-10-2026
yahoo.com
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
07-10-2026
yahoo.com
Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes
13-10-2026
yahoo.com
Kura Oncology Launches $50M-Backed Diabetes Venture for Oral Menin Inhibitor
14-10-2026
marketbeat.com
Will Kura Oncology (KURA) Report Negative Q3 Earnings? What You Should Know
27-10-2026
yahoo.com
What is the current price of KURA ONCOLOGY INC (KURA:NASDAQ)?
The current price of KURA ONCOLOGY INC (KURA:NASDAQ) is $9.82.
KURA ONCOLOGY INC (KURA:NASDAQ) absolute price change since previous trading day?
The absolute price change of KURA ONCOLOGY INC (KURA:NASDAQ) since the previous trading day is $0.2.
KURA ONCOLOGY INC (KURA:NASDAQ) percentage price change since previous trading day?
The percentage price change of KURA ONCOLOGY INC (KURA:NASDAQ) since the previous trading day is 2.079%.
What is the most recent average sentiment score for KURA ONCOLOGY INC (KURA:NASDAQ)?
The most recent average sentiment score for KURA ONCOLOGY INC (KURA:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for KURA ONCOLOGY INC (KURA:NASDAQ)?
The most recent sentiment for KURA ONCOLOGY INC (KURA:NASDAQ) is .
SEC-8K** Filing Available For KURA ONCOLOGY INC (KURA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.